mortality/aging
|
• although mice are born at expected Mendelian ratios, less than 20% of mice survive past 24 months of age versus >60% of wild-type controls
|
cardiovascular system
|
• at 12 months of age, H&E analysis of transverse sections indicates only a slight dilation of the heart left ventricle
• however, overall adult heart anatomy and morphology are normal
|
|
• at 8 months of age, mice show a slight decrease in the left ventricular ejection fraction relative to wild-type controls
|
|
• mice are more susceptible to cardiac arrhythmias in response to catecholamine challenge with isoproterenol
• however, electrocardiographic parameters are normal in the absence of isoproterenol treatment
|
|
• mice show a significant increase in the duration of individual episodes of ventricular tachycardia (VT) during a 30-min period after intraperitoneal isoproterenol injection
|
|
• mice show a significant increase in the rate of premature ventricular contractions (PVCs), expressed as times / 30 min, after intraperitoneal isoproterenol injection
|
|
• isoproterenol-treated adult mouse cardiomyocytes (AMCMs) isolated from 5-mo-old mice show a significantly lower increase in the peak amplitude of Ca2+ transients than similarly treated wild-type AMCMs (+29% versus +44%)
• isoproterenol-treated caffeine-induced AMCMs exhibit a significantly higher sarcoplasmic reticulum (SR) Ca2+ content than similarly treated wild-type AMCMs
• overexpression of human cardiac triadin (Trisk32) in AMCMs by adenoviral delivery restores the amplitude of Ca2+ transients to the level in wild-type AMCMs after isoproterenol treatment
|
homeostasis/metabolism
|
• mice show a significant reduction in involuntary running distance in a treadmill endurance test
|
|
• isoproterenol-treated adult mouse cardiomyocytes (AMCMs) isolated from 5-mo-old mice show a significantly lower increase in the peak amplitude of Ca2+ transients than similarly treated wild-type AMCMs (+29% versus +44%)
• isoproterenol-treated caffeine-induced AMCMs exhibit a significantly higher sarcoplasmic reticulum (SR) Ca2+ content than similarly treated wild-type AMCMs
• overexpression of human cardiac triadin (Trisk32) in AMCMs by adenoviral delivery restores the amplitude of Ca2+ transients to the level in wild-type AMCMs after isoproterenol treatment
|
|
• qPCR analysis shows that expression of MT-1, the cardiac-predominant isoform produced by alternative splicing of the Trdn (triadin) gene, is downregulated by ~30% and 50% in adult hearts at 4- and 8 months of age, respectively, leading to a marked reduction in cardiac TRDN protein levels
• re-expression of Trdnos in AMCMs by adenoviral delivery normalizes MT-1 expression at both the mRNA and protein levels
|
behavior/neurological
|
• mice show a significant reduction in involuntary running distance in a treadmill endurance test
|
muscle
|
• at 8 months of age, mice show a slight decrease in the left ventricular ejection fraction relative to wild-type controls
|
|
• isoproterenol-treated adult mouse cardiomyocytes (AMCMs) isolated from 5-mo-old mice show a significantly lower increase in the peak amplitude of Ca2+ transients than similarly treated wild-type AMCMs (+29% versus +44%)
• isoproterenol-treated caffeine-induced AMCMs exhibit a significantly higher sarcoplasmic reticulum (SR) Ca2+ content than similarly treated wild-type AMCMs
• overexpression of human cardiac triadin (Trisk32) in AMCMs by adenoviral delivery restores the amplitude of Ca2+ transients to the level in wild-type AMCMs after isoproterenol treatment
|


Analysis Tools